Literature DB >> 8595884

U1 snRNA promotes the selection of nearby 5' splice sites by U6 snRNA in mammalian cells.

D Y Hwang1, J B Cohen.   

Abstract

Communication between exon boundaries is a central feature of the exon definition model of pre-mRNA splice-site selection and an exon-bridging interaction involving U1 small nuclear RNA (snRNA) paired with the 5' splice site (5'ss) has been identified previously. It has become increasingly clear, however, that the 5'ss is not defined relative to the base-pairing interaction with U1, suggesting that a connection in the proposed line of communication between exon boundaries is missing. To explore this issue, we have first sought to characterize the role in mammalian 5'ss selection of a previously suggested base-pairing interaction with U6 snRNA. Using transfection experiments, we show that mutations at positions 5 and 6 of a 5'ss associated with an internal exon can be suppressed by compensatory changes in the first two positions of a conserved hexanucleotide of U6 RNA. The specificity of the effect was established by covariation experiments as well as by experiments with two splice sites arranged in tandem. Suppression of 5'ss mutations by U6 was more efficient when U1 could pair nearby than when pairing was restored further away and individual U1 RNAs stimulated U6-defined proximal sites more efficiently than distal sites. These results are interpreted to suggest that U1 acts to direct 5'ss choice by U6 to matching sequences nearby. Our work supports a central role for base-pairing with U6 snRNA in mammalian 5'ss selection and suggests how the interaction may be established properly despite the limited complementarity involved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8595884     DOI: 10.1101/gad.10.3.338

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  28 in total

1.  Splicing enhancement in the yeast rp51b intron.

Authors:  D Libri; A Lescure; M Rosbash
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

2.  A ribozyme selected from variants of U6 snRNA promotes 2',5'-branch formation.

Authors:  T Tuschl; P A Sharp; D P Bartel
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

3.  An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Activation of a cryptic 5' splice site by U1 snRNA.

Authors:  C J Alvarez; J A Wise
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

5.  Efficient use of a 'dead-end' GA 5' splice site in the human fibroblast growth factor receptor genes.

Authors:  Simon Brackenridge; Andrew O M Wilkie; Gavin R Screaton
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

6.  Determinants of the inherent strength of human 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

7.  Protein-free spliceosomal snRNAs catalyze a reaction that resembles the first step of splicing.

Authors:  Saba Valadkhan; Afshin Mohammadi; Chaim Wachtel; James L Manley
Journal:  RNA       Date:  2007-10-16       Impact factor: 4.942

8.  Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides.

Authors:  Xavier Roca; Martin Akerman; Hans Gaus; Andrés Berdeja; C Frank Bennett; Adrian R Krainer
Journal:  Genes Dev       Date:  2012-05-15       Impact factor: 11.361

9.  Base pairing at the 5' splice site with U1 small nuclear RNA promotes splicing of the upstream intron but may be dispensable for slicing of the downstream intron.

Authors:  D Y Hwang; J B Cohen
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Base pairing with U6atac snRNA is required for 5' splice site activation of U12-dependent introns in vivo.

Authors:  R Incorvaia; R A Padgett
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.